---
title: "European Equities Traded in the US as American Depositary Receipts Higher Monday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279292207.md"
description: "European equities traded in the US as American depositary receipts rose 1.7% to 1,741.84 on the S&P Europe Select ADR Index. Notable gainers included Turbo Energy (TURB) up 7.5%, Abivax (ABVX) up 5.7%, and Nokia (NOK) up 4.3%. Decliners included Evaxion (EVAX) down 7.3%, Cadeler (CDLR) down 4%, and DBV Technologies (DBVT) down 0.8%. From the UK and Ireland, Silence Therapeutics (SLN) rose 5.9% and Carnival (CUK) rose 3.8%, while Akari Therapeutics (AKTX) fell 7.7% and Biodexa Pharmaceuticals (BDRX) fell 4%."
datetime: "2026-03-16T15:22:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279292207.md)
  - [en](https://longbridge.com/en/news/279292207.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279292207.md)
---

# European Equities Traded in the US as American Depositary Receipts Higher Monday

11:22 AM EDT, 03/16/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were rising on Monday morning, up 1.7% to 1,741.84 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by solar energy technology company Turbo Energy ( TURB ) and clinical stage biotechnology company Abivax ( ABVX ) , which rose 7.5% and 5.7% respectively. They were followed by telecommunications and consumer electronics company Nokia ( NOK ) , which added 4.3%.

The decliners from continental Europe were led by biotech company Evaxion ( EVAX ) and construction engineering company Cadeler ( CDLR ) , which fell 7.3% and 4% respectively. They were followed by clinical stage biopharmaceutical company DBV Technologies ( DBVT ) , which was down 0.8%.

From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics ( SLN ) and cruise line operator Carnival (CUK), which rose 5.9% and 3.8% respectively.

The decliners from the UK and Ireland were led by oncology biotech company Akari Therapeutics ( AKTX ) and clinical stage biotech company Biodexa Pharmaceuticals ( BDRX ) , which lost 7.7% and 4% respectively.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [CCL.US](https://longbridge.com/en/quote/CCL.US.md)
- [BDRX.US](https://longbridge.com/en/quote/BDRX.US.md)
- [CUK.US](https://longbridge.com/en/quote/CUK.US.md)
- [ABVX.US](https://longbridge.com/en/quote/ABVX.US.md)
- [EVAX.US](https://longbridge.com/en/quote/EVAX.US.md)
- [CCL.UK](https://longbridge.com/en/quote/CCL.UK.md)
- [SLN.US](https://longbridge.com/en/quote/SLN.US.md)
- [SPEU.US](https://longbridge.com/en/quote/SPEU.US.md)

## Related News & Research

- [CARNIVAL CORPORATION DECLARES DIVIDEND | CCL Stock News](https://longbridge.com/en/news/285768957.md)
- [Carnival Unifies Dual Structure Under Single Bermuda Entity](https://longbridge.com/en/news/285635436.md)
- [Carnival Corporation $CCL Shares Sold by Kornitzer Capital Management Inc. KS](https://longbridge.com/en/news/285057193.md)
- [SEABOURN ANNOUNCES NEW 2028-2029 EXPEDITION VOYAGES, INCLUDING SECOND GRAND EXPEDITION: POLE TO POLE AND ENHANCED ARCTIC SAILINGS | CCL Stock News](https://longbridge.com/en/news/283696171.md)
- [Evaxion A/S Wins Shareholder Approval for Expanded Equity and Convertible Financing Powers](https://longbridge.com/en/news/283662971.md)